Occurrence of extended-spectrum β-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens in Korea and investigation of screening criteria

Diagnostic Microbiology and Infectious Disease

Volumn 51, Issue 4, 2005, Pages 265-269

  Park, Yeon Joon ^a   Park, Sun Young ^a   Oh, Eun Jee ^a   Park, Jung Jun ^a   Lee, Kyo Young ^a   Woo, Gun Jo ^b   Lee, Kyungwon ^c  

^a The Catholic University of Korea   (South Korea)

^b Korea Food and Drug Administration   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Citrobacter freundii; Enterobacter cloacae; Extended spectrum lactamase; Screening criteria; Serratia marcescens

Indexed keywords

ACID; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BACTERIAL ENZYME; BETA LACTAMASE; BETA LACTAMASE AMPC; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CLAVULANIC ACID; ENZYME INHIBITOR;

ACCURACY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL GENE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CITROBACTER FREUNDII; CLINICAL LABORATORY; CONJUGATION; CONTROLLED STUDY; DIFFUSION; ENTEROBACTER CLOACAE; ENZYME SYNTHESIS; KOREA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCREENING TEST; SERRATIA MARCESCENS; STRUCTURAL GENE;

EID: 16244389656     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2004.11.009     Document Type: Article

References (26)

1. J.M. Bell, J.D. Turnidge, and R.N. Jones SENTRY Asia-Pacific participants. Prevalence of extended-spectrum β-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: Results from the SENTRY antimicrobial surveillance program, 1998-2001 Antimicrob. Agents Chemother. 47 2003 3989 3993
2. R. Bonnet Growing group of extended-spectrum β-lactamases: The CTX-M enzymes Antimicrob. Agents Chemother. 48 2004 1 14
3. K. Bush, G.A. Jacoby, and A.A. Medeiors A functional classification scheme for β-lactamases and its correlation with molecular structure Antimicrob. Agents Chemother. 39 1995 1211 1233
4. R. Cantón, A. Oliver, T.M. Coque, C. Del Varela Mdel, J.C. Pérez-Diaz, and F. Baquero Epidemiology of extended-spectrum β-lactamase-producing Enterobacter isolates in a Spanish hospital during a 12-year period J. Clin. Microbiol. 40 2002 1237 1243
5. F. Danel, L.M. Hall, D. Gur, H.E. Akalin, and D.M. Livermore Transferable production of PER-1 β-lactamase in Pseudomonas aeruginosa J. Antimicrob. Chemother. 35 1995 281 294
6. C. De Champs, D. Sirot, C. Chanal, R. Bonnet, and J. Sirot A 1998 survey of extended-spectrum-β-lactamases in Enterobacteriaceae in France Antimicrob. Agents Chemother. 44 2000 3177 3179
7. D. Gianneli, E. Tzelepi, L.S. Tzouvelekis, A.F. Mentis, and C. Nikolopoulou Dissemination of cephalosporin-resistant Serratia marcescens strains producing a plasmidic SHV type β-lactamase in Greek hospitals Eur. J. Clin. Microbiol. Infect. Dis. 13 1994 764 767
8. S.H. Jeong, I.K. Bae, S.B. Kwon, J.H. Lee, H.I. Jung, J.S. Song, B.C. Jeong, S.J. Kim, and S.H. Lee Investigation of extended-spectrum-B-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli in Korea Lett. Appl. Microbiol. 39 2004 41 47
9. J. Kim, Y. Kwon, H. Pai, J.W. Kim, and D.T. Cho Survey of Klebsiella pneumoniae strains producing extended-spectrum β-lactamases: Prevalence of SHV-12 and SHV-2a in Korea J. Clin. Microbiol. 36 1998 1446 1449
10. H. Knothe, P. Shah, V. Krcmery, M. Antal, and S. Mitsuhashi Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens Infection 11 1983 315 317
11. D.M. Livermore, T.G. Winstanley, and K.P. Shannon Interpretative reading: Recognizing the unusual and inferring resistance mechanisms from resistance phenotypes J. Antimicrob. Chemother. 48 Suppl. S1 2001 87 102
12. F. Luzzaro, M. Perilli, R. Migliavacca, G. Lombardi, P. Micheletti, A. Agodi, S. Stefani, G. Amicosante, and L. Pagani Repeated epidemics caused by extended-spectrum beta-lactamase-producing Serratia marcescens strains Eur. J. Clin. Microbiol. Infect. Dis. 17 1998 629 636
13. C. Mabilat, and S. Goussard PCR detection and identification of genes for extended-spectrum β-lactamases D.H. Persing T.F. Smith F.C. Tenover Diagnostic molecular microbiology 1993 American Society for Microbiology Washington 553 559
14. NCCLS Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically-sixth edition: Approved standard Guideline M7-A6 2003 NCCLS Washington 1-56238-486-4
15. NCCLS Performance standards for antimicrobial susceptibility testing: fourteenth informational supplement NCCLS document M100-S14 2004 NCCLS Wayne (PA) 1-56238-516-X
16. S. Navon-Venezia, O. Hammer-Munz, D. Schwartz, D. Turner, B. Kuzmenko, and Y. Carmeli Occurrence and phenotypic characteristics of extended-spectrum β-lactamases among members of the family Enterobacteriaceae at the Tel-Aviv medical center (Israel) and evaluation of diagnostic tests J. Clin. Microbiol. 41 2003 155 158
17. Y.J. Park, S. Lee, D. Yong, K. Lee, B.K. Kim, and C.S. Kang Antimicrobial susceptibility of inducible AmpC β-lactamase-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens: A Korean Survey Kor. J. Lab. Med. 23 2003 251 257
18. M. Saladin, V.T. Cao, T. Lambert, J.L. Donay, J.L. Herrmann, Z. Ould-Hocine, C. Verdet, F. Delsile, A. Philippon, and G. Arlet Diversity of CTX-M β-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals FEMS Microbiol. Lett. 209 2002 161 168
19. W.E. Sanders Jr., and C.C. Sanders Enterobacter spp.: Pathogens poised to flourish at the turn of the century Clin. Microbiol. Rev. 10 1997 220 241
20. M.J. Schwaber, P.M. Raney, J.K. Rasheed, J.W. Biddle, P. Williams, J.E. McGowan Jr., and F.C. Tenover Utility of NCCLS guidelines for identifying extended-spectrum β-lactamases in non-Escherichia coli and non-Klebsiella spp. of Enterobacteriaceae J. Clin. Microbiol. 42 2004 294 298
21. E. Stürenburg, I. Sobottka, D. Noor, R. Laufs, and D. Mack Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum β-lactamases in an Enterobacteriaceae strain collection J. Antimicrob. Chemother. 54 2004 134 138
22. A. Thiolas, C. Bornet, A. Davin-Regil, J.M. Pages, and C. Bollet Resistance to imipenem, cefepime, and cefpirome associated with mutation in Omp36 osmoporin of Enterobacter aerogenes Biochem. Biophys. Res. Commun. 317 2004 851 856
23. K.S. Thomson, C.C. Sanders, and E.S. Moland Use of microdilution panels with and without β-lactamase inhibitors as a phenotypic test for β-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens Antimicrob. Agents Chemother. 43 1999 1393 1400
24. E. Tzelepi, P. Giakkoupi, D. Sofianou, V. Loukova, A. Kemeroglou, and A. Tsakris Detection of extended-spectrum β-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes J. Clin. Microbiol. 38 2000 542 546
25. D. Yong, J.H. Shin, S. Kim, Y. Lim, J.H. Yum, K. Lee, Y. Chong, and A. Bauernfeind High prevalence of PER-1 extended-spectrum β-lactamase- producing Acinetobacter spp. in Korea Antimicrob. Agents Chemother. 47 2003 1749 1751
26. M.H. Zeig Evaluation of the clinical accuracy of laboratory tests Arch. Pathol. Lab. Med. 112 1998 383 386